BIOMAT Database Logo BIOMAT Database Logo

Halothane: how should it be used in a developing country? 2012

N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

The anaesthetic agent halothane is still widely used in developing countries including the Islamic Republic of Iran because of its low price. Because of halothane-induced hepatitis, a rare complication, it has been replaced by other inhalation anaesthetics in Western countries; it has been suggested by some Iranian professionals that the Islamic Republic of Iran should do the same. We evaluated various dimensions of this replacement through a literature review to assess the incidence of halothane-induced hepatitis and costs of anaesthetics in the country. We also conducted a questionnaire survey of 30 anaesthesiology/gastroenterology experts about their views on the subject. The results indicate that the incidence of halothane hepatitis in the Islamic Republic of Iran is very low and could mostly be avoided by strict adherence to guidelines. Complete withdrawal of halothane in the Islamic Republic of Iran might not be appropriate at present. Comprehensive cost-effectiveness studies are needed before a decision is made on complete replacement of halothane with other anaesthetics.

UI MeSH Term Description Entries
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D008738 Methyl Ethers A group of compounds that contain the general formula R-OCH3. Ethers, Methyl
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D003365 Costs and Cost Analysis Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. Affordability,Analysis, Cost,Cost,Cost Analysis,Cost Comparison,Cost Measures,Cost-Minimization Analysis,Costs and Cost Analyses,Costs, Cost Analysis,Pricing,Affordabilities,Analyses, Cost,Analyses, Cost-Minimization,Analysis, Cost-Minimization,Comparison, Cost,Comparisons, Cost,Cost Analyses,Cost Comparisons,Cost Measure,Cost Minimization Analysis,Cost, Cost Analysis,Cost-Minimization Analyses,Costs,Measure, Cost,Measures, Cost
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077149 Sevoflurane A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION. BAX 3084,Fluoromethyl Hexafluoroisopropyl Ether,Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl Ether,Sevorane,Ultane
D000077335 Desflurane A fluorinated ether that is used as a volatile anesthetic for maintenance of general anesthesia. 1,2,2,2-Tetrafluoroethyl difluoromethyl ether,I 653,I-653,I653,Suprane

Related Publications

N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Ibopamine--how should it be used?
January 1988, Cardiology,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
[Isotretinoin. How should it be used?].
April 2013, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Acyclovir: how often should it be used?
February 1994, The Journal of family practice,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Quinquinia-Why It Should Be Used by Country Practitioners.
August 1880, The Chicago medical journal and examiner,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
[Which topical corticoid and how should it be used?].
March 1990, Revue medicale de la Suisse romande,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Granulocyte transfusion – when and how should it be used?
March 2018, Lakartidningen,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
BCG vaccine; what it is and how it should be used.
June 1948, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Editorial. Systematic review--what is it and how should it be used?
August 2004, Manual therapy,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Which preparation of botulinum toxin a should be used, where should it be injected, and how should its efficacy be assessed?
May 2012, European urology,
N Mahboobi, and S Esmaeili, and S Safari, and P Habibollahi, and A Dabbagh, and S M Alavian
Dipyridamole/thallium-201 imaging: how safe is it? When should it be used?
November 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!